VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

NCT05715125 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

205

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Psoriatic Arthritis

Interventions

DRUG: Dose A VTX958
DRUG: Dose B VTX958
DRUG: Placebo

Sponsor

Ventyx Biosciences, Inc